(1)
In-Silico Studies of Heterocyclic Benzoxazole Derivatives As an Anticancer Agent: Molecular Docking, 2D and 3D QSAR . Int. J. Pharm. Sci. Drug Res. 2023, 15 (6), 780-788. https://doi.org/10.25004/IJPSDR.2023.150612.